EDGAR Filing Documents for 0001144204-07-066940

Form 8-K - Current report:

SEC Accession No. 0001144204-07-066940

Filing Date

2007-12-11

Accepted

2007-12-11 16:45:24

Documents

Period of Report

2007-12-05

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		v096955_8k.htm	8-K	37206
2		v096955_ex3-2.htm	EX-3.2	234475
3		v096955_ex10-43.htm	EX-10.43	165795
4		v096955_ex10-53.htm	EX-10.53	63502
	Complete submission text file	0001144204-07-066940.txt		502793

Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080

Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500

SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 071299448
SIC: 2834 Pharmaceutical Preparations